This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Mangogen Pharma Inc.. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2022
Introduction
Arghya Paul is a notable inventor based in Longueuil, Canada. He has made significant contributions to the field of medical innovations, particularly through his work on viral microparticles for therapeutic applications. With two patents to his name, he is pushing the boundaries of technology in healthcare.
Latest Patents
Arghya Paul’s latest patents encompass groundbreaking research on therapeutic viral microparticles aimed at promoting stent biofunctionality and enhancing wound healing in vertebrate individuals. These patents detail the composition of viral microparticles that consist of genetically-engineered baculoviruses embedded within a polymeric matrix. The innovative design allows for localized delivery of therapeutic nucleic acid molecules to the cells of a vertebrate individual, especially when combined with medical implants like vascular stent platforms. The therapeutic microparticles are beneficial for wound healing, blood vessel repair, and preventing pathological scarring. The patents also outline processes for fabricating these viral microparticles, along with pharmaceutical compositions using them, and support mechanisms for accurately placing the microparticles near wounds.
Career Highlights
Arghya Paul works at Mangogen Pharma Inc., where he leverages his expertise to advance innovative therapeutic solutions. His contributions have not only led to significant patent achievements but also solidified his status as a pioneering inventor in the biopharmaceutical sector.
Collaborations
In his professional journey, Arghya has collaborated with esteemed colleagues including Satya Prakash and Dominique Shum-Tim. These collaborations have likely enriched his research and development endeavors, fostering an environment of shared knowledge and innovation.
Conclusion
Arghya Paul stands out as a distinguished inventor who is making substantial strides in the realm of medical technology. His focus on viral microparticles showcases his commitment to enhancing therapeutic interventions and improving healthcare outcomes. As his innovations continue to evolve, they promise to play a pivotal role in the future of medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile